66 related articles for article (PubMed ID: 6701006)
1. [Protaminase activity of plasma and serum in vitro. II.- Electrophoretic study of serum albumin-protamine soluble complexes].
Blass J; Verriest C; Vicaigne MB; Detruit H; Weiss M
Pathol Biol (Paris); 1984 Jan; 32(1):40-4. PubMed ID: 6701006
[TBL] [Abstract][Full Text] [Related]
2. ["In vitro" protaminase activity of human plasma and serum and the human carboxypeptidase N (author's transl)].
Blass J; Verriest C; Vicaigne MB; Weiss M
Pathol Biol (Paris); 1980 Oct; 28(8):527-34. PubMed ID: 6448971
[TBL] [Abstract][Full Text] [Related]
3. Determination of "in vitro" degradation of protamine in plasma by three different methods.
Weiss M; Blass J; Detruit H; Aime L; Baudet B; Fiancette JY; Gaillard M; Vicaigne MB; Verriest C
Thromb Res; 1986 Mar; 41(5):593-604. PubMed ID: 3961737
[TBL] [Abstract][Full Text] [Related]
4. [Protaminase activity of plasma. III. Role of conversion enzyme (kininase II) in protaminase activity of plasma].
Blass J; Detruit H; Aime L; Fiancette JY; Gaillard M; Verriest C; Vicaigne MB; Weiss M
Pathol Biol (Paris); 1988 Dec; 36(10):1192-8. PubMed ID: 2853323
[TBL] [Abstract][Full Text] [Related]
5. [Degradation of protamine and protamine-heparin complexes by proteolytic enzymes of blood serum and serum euglobulin fractions].
Roszkowska W; Worowski K; Ostrowska H
Acta Haematol Pol; 1984; 15(1-2):43-7. PubMed ID: 6516712
[No Abstract] [Full Text] [Related]
6. Heparin-protamine complexes and C-reactive protein induce activation of the classical complement pathway: studies in patients undergoing cardiac surgery and in vitro.
Bruins P; te Velthuis H; Eerenberg-Belmer AJ; Yazdanbakhsh AP; de Beaumont EM; Eijsman L; Trouwborst A; Hack CE
Thromb Haemost; 2000 Aug; 84(2):237-43. PubMed ID: 10959695
[TBL] [Abstract][Full Text] [Related]
7. Complexes of a modified low-molecular-weight heparin with protamine are predominantly cleared by a macrophage scavenger receptor-mediated process in rats.
Stehle G; Wunder A; Sinn H; Schrenk HH; Friedrich EA; Dempfle CE; Maier-Borst W; Heene DL
J Surg Res; 1995 Feb; 58(2):197-204. PubMed ID: 7861773
[TBL] [Abstract][Full Text] [Related]
8. Protamine inhibits plasma carboxypeptidase N, the inactivator of anaphylatoxins and kinins.
Tan F; Jackman H; Skidgel RA; Zsigmond EK; Erdös EG
Anesthesiology; 1989 Feb; 70(2):267-75. PubMed ID: 2913861
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass.
Tao W; Deyo DJ; Brunston RL; Vertrees RA; Grochoske TL; Zwischenberger JB
ASAIO J; 1997; 43(5):M825-30. PubMed ID: 9360162
[TBL] [Abstract][Full Text] [Related]
10. Involvement of fibrinogen in protamine-induced pulmonary hypertension.
Sogawa M; Mohammad SF
J Surg Res; 1997 Nov; 73(1):80-4. PubMed ID: 9441797
[TBL] [Abstract][Full Text] [Related]
11. Fluorometric determination of heparin based on self-quenching of fluorescein-labeled protamine.
Egawa Y; Hayashida R; Seki T; Anzai J
Talanta; 2008 Aug; 76(4):736-41. PubMed ID: 18656650
[TBL] [Abstract][Full Text] [Related]
12. PEG-modified protamine with improved pharmacological/pharmaceutical properties as a potential protamine substitute: synthesis and in vitro evaluation.
Chang LC; Lee HF; Chung MJ; Yang VC
Bioconjug Chem; 2005; 16(1):147-55. PubMed ID: 15656586
[TBL] [Abstract][Full Text] [Related]
13. Oligonucleotide-protamine-albumin nanoparticles: Protamine sulfate causes drastic size reduction.
Mayer G; Vogel V; Weyermann J; Lochmann D; van den Broek JA; Tziatzios C; Haase W; Wouters D; Schubert US; Zimmer A; Kreuter J; Schubert D
J Control Release; 2005 Aug; 106(1-2):181-7. PubMed ID: 16002173
[TBL] [Abstract][Full Text] [Related]
14. A comparison of thromboelastography with heparinase or protamine sulfate added in vitro during heparinized cardiopulmonary bypass.
Spiess BD; Wall MH; Gillies BS; Fitch JC; Soltow LO; Chandler WL
Thromb Haemost; 1997 Aug; 78(2):820-6. PubMed ID: 9268178
[TBL] [Abstract][Full Text] [Related]
15. [Effect of protamine sulphate on erythrocyte agglutination by anti-rh antisera. Cause of time-dependence (author's transl)].
Franz H; Haustein B; Geske K; Kuropka U; Pfüller U
Z Immunitatsforsch Immunobiol; 1976; 151(4):350-8. PubMed ID: 820102
[TBL] [Abstract][Full Text] [Related]
16. Plasma procarboxypeptidase U in men with symptomatic coronary artery disease.
Silveira A; Schatteman K; Goossens F; Moor E; Scharpé S; Strömqvist M; Hendriks D; Hamsten A
Thromb Haemost; 2000 Sep; 84(3):364-8. PubMed ID: 11019956
[TBL] [Abstract][Full Text] [Related]
17. [Characterization of the protamine-hydrolyzing enzyme activity of the rat serum].
Kleine R; Tille D
Acta Biol Med Ger; 1969; 22(3):525-35. PubMed ID: 4983226
[No Abstract] [Full Text] [Related]
18. [Properties of protamine-heparin complexes].
Roszkowska W; Worowski K
Acta Haematol Pol; 1979; 10(1):39-46. PubMed ID: 155386
[TBL] [Abstract][Full Text] [Related]
19. The three-dimensional structures of tick carboxypeptidase inhibitor in complex with A/B carboxypeptidases reveal a novel double-headed binding mode.
Arolas JL; Popowicz GM; Lorenzo J; Sommerhoff CP; Huber R; Aviles FX; Holak TA
J Mol Biol; 2005 Jul; 350(3):489-98. PubMed ID: 15961103
[TBL] [Abstract][Full Text] [Related]
20. A pilot study indicating that bradykinin B2 receptor antagonism attenuates protamine-related hypotension after cardiopulmonary bypass.
Pretorius M; Scholl FG; McFarlane JA; Murphey LJ; Brown NJ
Clin Pharmacol Ther; 2005 Nov; 78(5):477-85. PubMed ID: 16321614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
